Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP482842.RAc-Sq61Httwgp5Orh1fCN1Cef0h6mLFRd2ONl3IeX1ok130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482842.RAc-Sq61Httwgp5Orh1fCN1Cef0h6mLFRd2ONl3IeX1ok130_provenance.
• NP486206.RAx0kaSJ_CbnisiF1AbT2w5yqFGEZ-NP4racm_YmLb9yw130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486206.RAx0kaSJ_CbnisiF1AbT2w5yqFGEZ-NP4racm_YmLb9yw130_provenance.
• NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_provenance.
• NP623011.RAY9kmb5wy4iRID2Gz-li37Yddo9TOpk-nrp41rGewAog130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623011.RAY9kmb5wy4iRID2Gz-li37Yddo9TOpk-nrp41rGewAog130_provenance.
• NP623552.RAclTimoPqU1LOVyUyYihPJpOzdRC2Z1fEU7qH2EnpwAI130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623552.RAclTimoPqU1LOVyUyYihPJpOzdRC2Z1fEU7qH2EnpwAI130_provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
• NP797919.RADNLB9-E9Z-ToVludBMl2S1q7QLKBblbG6TxdTiyuT7Y130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797919.RADNLB9-E9Z-ToVludBMl2S1q7QLKBblbG6TxdTiyuT7Y130_provenance.
• NP797916.RAXcpfLEhl6lko0TzWHpYe70C6sAyGDROI2_tGPatwUKw130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797916.RAXcpfLEhl6lko0TzWHpYe70C6sAyGDROI2_tGPatwUKw130_provenance.
• NP797917.RAfLgEelKOLEqlZf54lBW54yZ_aSV--Y5wP3YIpm72hig130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797917.RAfLgEelKOLEqlZf54lBW54yZ_aSV--Y5wP3YIpm72hig130_provenance.
• NP797921.RAd2MUiwWC6wrZuVN5ImPtBuLGwRMROpF9Cb7kB0c46O8130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797921.RAd2MUiwWC6wrZuVN5ImPtBuLGwRMROpF9Cb7kB0c46O8130_provenance.
• NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_provenance.
• NP797922.RAuVO65bz-0BHewyvYsEiMKUGdMm-TCWMCXTzFx_MaFLM130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797922.RAuVO65bz-0BHewyvYsEiMKUGdMm-TCWMCXTzFx_MaFLM130_provenance.
• NP624680.RAF2VnoFdeEZh4tmI1CrxnjPoqdBCJqJgnBVDYkCqF648130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624680.RAF2VnoFdeEZh4tmI1CrxnjPoqdBCJqJgnBVDYkCqF648130_provenance.
• NP625467.RAHf3T4oEMhHG-3SxIQLHeXno8BCiZQAPsVWsMtBYT1q0130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625467.RAHf3T4oEMhHG-3SxIQLHeXno8BCiZQAPsVWsMtBYT1q0130_provenance.
• NP622237.RA--4BqeejXjoneok5bgH4bltWSw82-TcHMz0i8tWvEcg130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622237.RA--4BqeejXjoneok5bgH4bltWSw82-TcHMz0i8tWvEcg130_provenance.
• NP797918.RAGZ8wTPILFvpsqYA4rgjdGBL7XBJJPr33APqK0tUwpbE130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797918.RAGZ8wTPILFvpsqYA4rgjdGBL7XBJJPr33APqK0tUwpbE130_provenance.
• NP797920.RAFUjCZlwKiu4vz1ggzV_ZIHzsSE-AB3KFHk18kZ-7mbk130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797920.RAFUjCZlwKiu4vz1ggzV_ZIHzsSE-AB3KFHk18kZ-7mbk130_provenance.
• NP797923.RA-MlXPRenVyeocV6sLsnw-Xsc5V1S5z1NhHn87sPFaX8130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797923.RA-MlXPRenVyeocV6sLsnw-Xsc5V1S5z1NhHn87sPFaX8130_provenance.